课题基金 / 基金详情

A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program

A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
糖皮质激素受体-SETDB2协同调控肝脏代谢基因计划
批准号:
10112447
负责人:
Timothy F Osborne
金额:
$53.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-08 至 2024-12-31
关键词:
AcuteAdverse effectsAffectAnti-Inflammatory AgentsAreaBindingCREB1 geneCardiovascular DiseasesCell NucleusChIP-seqChromatinChromatin LoopChronicClinicalCodeCollaborationsCytoplasmDNA receptorDataDevelopmentDexamethasoneDiabetes MellitusDiseaseEnhancersEnzymesEpigenetic ProcessEquilibriumExposure toFastingFatty LiverFatty acid glycerol estersGene ActivationGene ExpressionGene Expression RegulationGene TargetingGenesGenomeGenomicsGlucagonGlucocorticoid ReceptorGlucocorticoidsGluconeogenesisGlucoseGlucose IntoleranceHepaticHomeostasisHormonalHormonesHumanHyperglycemiaHyperlipidemiaInsulin ResistanceKnock-outKnowledgeLeadLipidsLiverLongitudinal StudiesMediatingMetabolicMetabolic DiseasesMetabolic dysfunctionMetabolic stressMetabolic syndromeMetabolismMolecularMusMuscular AtrophyNon-Insulin-Dependent Diabetes MellitusNutritionalObesityPathway interactionsPatientsPhysiologicalPlayPostabsorptive HypoglycemiaProteinsPublishingRegulationResearchResponse ElementsRisk FactorsRoleSET DomainSiteStressStudy modelsTransactivationUntranslated RNAVisceral fatWeight GainWeights and MeasuresWorkcell typechromatin modificationclinically relevantdiet-induced obesityepigenomicsexperimental studyfeedinggene repressiongenome-wideglucocorticoid receptor alphaglucose productionhuman diseasehypercholesterolemiaimmunoregulationinsightliver metabolismmouse genomemouse modelnew therapeutic targetnovelnovel therapeutic interventionpreventprogramspromoterreceptor functionrecruitresponseside effectsynergismtranscription factortranscriptome sequencing

项目摘要

项目成果

Timothy F Osborne的其他基金

相似基金

相关文献

中文摘要
翻译
过量的糖皮质激素会导致糖尿病和代谢综合征的发展,包括:肥胖、高血糖、高胆固醇血症、胰岛素抵抗和肝脏脂肪变性。糖皮质激素通过糖皮质激素受体(GR)发挥其生理作用,GR是一种转录因子,与GRE基序上的染色质结合,导致基因激活或抑制。我们发表的工作发现了一种先前未知的GR介导的基因调控机制,该机制通过与SET结构域包含蛋白SETDB2合作,激活与糖尿病相关的肝脏中GR基因靶点的选定子集。我们发现SETDB2s缺陷小鼠的肝脏对糖皮质激素的反应明显迟钝,表现为空腹低血糖和缺乏关键GR靶基因的诱导。由于抑制肝脏中糖皮质激素的作用可以防止糖皮质激素诱导的糖尿病的负面代谢影响,我们假设肝脏特异性 当暴露在导致糖皮质激素升高的条件下时,SETDB2基因敲除(DB2LKO)小鼠将受到部分保护,免受代谢功能障碍的影响。通过评价肝脏特异的DB2LKO和肝脏特异的GR-LKO在内源性糖皮质激素升高(饮食诱导的肥胖)或外源性糖皮质激素应用的条件下对糖脂平衡的影响,研究了与糖皮质激素诱导的代谢性疾病相关的基本机制。将测量与糖尿病相关的代谢参数:体重增加、糖耐量减低、胰岛素抵抗、高脂血症和肝脏脂肪变性。此外,将在这些实验范例中描述SETDB2GR联合作用的分子机制,并将通过RNA-SEQ、CHIP-SEQ和Hi-CHIP识别新的基因靶点和染色质靶向。整合拟议的实验将更好地理解SETDB2s如何影响GR的积极和消极作用,这些作用与肝脏中的代谢性疾病有关。这个 研究的基本机制可能为靶向SETDB2GR作用的新基因S提供一条途径 糖皮质激素所致糖尿病和代谢性疾病的治疗靶点。这些实验在小鼠模型中平衡了机械性和探索性研究,以研究与人类疾病直接相关的肝脏代谢过程的调节。这两个目标的结果将被整合在一起,以揭示SETDB2GR调节轴有助于肝脏适应急性营养状态(目标1)、慢性营养状态和荷尔蒙状态(目标2)的重叠和独特的机制。
英文摘要
Excess glucocorticoids contribute to the development of diabetes and metabolic syndrome, which includes: obesity, hyperglycemia, hypercholesterolemia, insulin resistance, and liver steatosis. Glucocorticoids exert their physiological effects via the glucocorticoid receptor (GR), a transcription factor that binds chromatin at GRE motifs leading to gene activation or repression. Our published work identified a previously unrecognized mechanism for GR-mediated gene regulation through its collaboration with the SET domain-containing protein, SETDB2, to activate a select subset of GR gene targets in the liver associated with diabetes. We showed livers of mice deficient in SETDB2 have a significantly blunted glucocorticoid response as demonstrated by fasting hypoglycemia and lack of induction of key GR target genes. Since inhibition of glucocorticoid action in liver can prevent the negative metabolic effects of glucocorticoid-induced diabetes, we hypothesize that liver-specific SETDB2-knockout (DB2-LKO) mice will be partially protected from metabolic dysfunction when exposed to conditions that lead to elevated glucocorticoids. Fundamental mechanisms associated with glucocorticoid-induced metabolic disease are studied by evaluating the effects of liver-specific DB2-LKO and liver-specific GR-LKO on glucose/lipid homeostasis under conditions of elevated endogenous glucocorticoids (diet- induced obesity) or exogenous glucocorticoid administration. Metabolic parameters associated with diabetes will be measured: weight gain, glucose-intolerance, insulin-resistance, hyperlipidemia, and hepatic steatosis. Additionally, the molecular mechanism for the combined action of SETDB2 and GR will be characterized within these experimental paradigms and novel gene targets and chromatin targeting will be identified by RNA-seq, ChIP-seq and Hi-ChIP. Integrating the proposed experiments will provide a better understanding of how SETDB2 affects the positive and negative actions of GR that are relevant to metabolic disease in the liver. The fundamental mechanism studied may provide a pathway to target SETDB2’s role in GR action as a new therapeutic target for glucocorticoid-induced diabetes and metabolic disease. The experiments a balance of mechanistic and exploratory studies in mouse models to investigate the regulation of hepatic metabolic processes that are directly relevant to human disease. The results from both aims will be integrated together to reveal the overlapping and unique mechanisms by which the SETDB2-GR regulatory axis contributes to the adaptation of the liver to acute nutritional (Aim 1), chronic nutritional and hormonal (Aim 2) states of metabolic stress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
  • 批准号:
    10326407
  • 项目类别:
  • 资助金额:
    $52.0万
  • 财政年份:
    2021
  • 负责人:
    Timothy F Osborne
  • 依托单位:
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
  • 批准号:
    10534202
  • 项目类别:
  • 资助金额:
    $52.51万
  • 财政年份:
    2021
  • 负责人:
    Timothy F Osborne
  • 依托单位:
Epigenetic regulation of adipose tissue distribution in women
  • 批准号:
    9306064
  • 项目类别:
  • 资助金额:
    $61.38万
  • 财政年份:
    2016
  • 负责人:
    Timothy F Osborne
  • 依托单位:
Physiology and regulation of T2R bitter taste receptors in enteroendocrine cells
海外基金